Soleno Therapeutics (SLNO) Retained Earnings (2013 - 2026)
Soleno Therapeutics' (SLNO) quarterly Retained Earnings came in at -$1.8 million in Q1 2026, up 99.63% year-on-year from -$920705.8 in Q1 2025, and up 99.57% on a QoQ basis from -$431.4 million in Q4 2025.
Soleno Therapeutics (SLNO) Retained Earnings (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 14 years of Retained Earnings data on file, last reported at -$1.8 million in Q1 2026.
- On a quarterly basis, Retained Earnings rose 99.63% year-over-year to -$1.8 million in Q1 2026; TTM through Mar 2026 was -$1.8 million, a 99.63% increase from a year earlier, with the FY2025 full-year figure at -$431.4 million, down 119593.07% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.8 million, up from -$431.4 million in the prior quarter.
- Over the last five years, Retained Earnings for SLNO reached as high as $361000.0 in Q4 2024 and fell as low as -$496.0 million in Q1 2025.
- Historically, Retained Earnings has averaged -$243.6 million across 5 years, with a median of -$254.3 million in 2023.
- Across the five-year window, Retained Earnings sank 13255600.0% in 2023 and surged 100.13% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$237.4 million in 2022, then decreased by 16.42% to -$276.4 million in 2023, then jumped by 100.13% to $361000.0 in 2024, then slumped by 119593.07% to -$431.4 million in 2025, then surged by 99.57% to -$1.8 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$1.8 million in Q1 2026, -$431.4 million in Q4 2025, and -$474.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | -1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.84 Mn |
| Dec 31, 2025 | -431.37 Mn |
| Sep 30, 2025 | -474.73 Mn |
| Jun 30, 2025 | 85,000.00 |
| Mar 31, 2025 | -496.03 Mn |
| Dec 31, 2024 | 361,000.00 |
| Sep 30, 2024 | -396.28 Mn |
| Jun 30, 2024 | -319.66 Mn |
| Mar 31, 2024 | -297.81 Mn |
| Dec 31, 2023 | -276.41 Mn |
| Sep 30, 2023 | -265.11 Mn |
| Jun 30, 2023 | -254.30 Mn |
| Mar 31, 2023 | -245.78 Mn |
| Dec 31, 2022 | -237.42 Mn |
| Sep 30, 2022 | -2,000.00 |
| Jun 30, 2022 | -225.80 Mn |
| Mar 31, 2022 | -219.10 Mn |
| Dec 31, 2021 | -213.36 Mn |
| Sep 30, 2021 | -210.50 Mn |
| Jun 30, 2021 | -202.39 Mn |